SCHEMBL6507080

SCHEMBL6507080

CCCNc1c(N)cccc1-c1nc2cc(Cl)cc(Cl)c2o1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.38
CETP P11597 1/20 0.37
CXCR4 P61073 1/20 0.34
CMKLR1 Q99788 1/20 0.34
ALDH1A1 P00352 5/20 0.34
KDM4E B2RXH2 5/20 0.34
SMN1; SMN2 Q16637 4/20 0.34
NPC1 O15118 3/20 0.34
RAB9A P51151 3/20 0.34
TP53 P04637 2/20 0.34
CASP3 P42574 1/20 0.34
SENP8 Q96LD8 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
HPGD P15428 4/20 0.34
GAA P10253 3/20 0.34
ALOX15 P16050 2/20 0.34
HSD17B10 Q99714 2/20 0.34
GLA P06280 1/20 0.34
CASP1 P29466 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6498374 0.83 CETP (0.39) MAPTCETPALDH1A1TP53GAA
SCHEMBL5834480 0.79 MAPT (0.42) MAPTCETPALDH1A1KDM4ESMN1; SMN2
SCHEMBL6507071 0.71 FERMT2 (0.41) MAPTCETPALDH1A1KDM4ESMN1; SMN2
SCHEMBL5834875 0.71 RIPK1 (0.44) MAPTCETPALDH1A1SMN1; SMN2TP53
SCHEMBL3633711 0.68 ALDH1A1 (0.44) ALDH1A1KDM4ESMN1; SMN2GAAKMT2A
SCHEMBL25292725 0.65 HDAC3 (0.39) MAPTCETPCXCR4CMKLR1ALDH1A1
SCHEMBL10725702 0.65 MAPT (0.47) MAPTCETPALDH1A1KDM4ESMN1; SMN2
SCHEMBL6498366 0.65 MAPT (0.37) MAPTCETPCXCR4CMKLR1ALDH1A1
SCHEMBL2245699 0.65 NPC1 (0.51) MAPTCETPALDH1A1KDM4ESMN1; SMN2
SCHEMBL11696963 0.65 MAPT (0.47) MAPTCETPSMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050203153-A1 Phthalimide carboxylic acid derivatives OXFORD GLYCOSCIENCE (UK) LTD. (GB) 2005-09-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050203153-A1 Phthalimide carboxylic acid derivatives H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HCCS, IDH1 MAPT 1342/4885CETP 4194/4885CXCR4 1276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.